TransCode Therapeutics (NASDAQ: RNAZ) reported continued progress in its Phase 1a trial of TTX-MC138, an RNA-based therapeutic targeting microRNA-10b ...

At the University of British Columbia, the Blakney Lab is focused on developing vaccines and therapies using self-amplifying ...

A new Stanford blood test detects cancer and tissue damage by analyzing rare RNA fragments in the blood. Stanford Medicine ...

The treatment, which aimed to block production of a mutant protein, reduced the frequency of infant’s seizures, but did not ...

Researchers at Karolinska Institutet and Uppsala University have developed a powerful new technique to better understand how ...

Creyon Bio, Inc. (Creyon) announced a global licensing and multi-target research collaboration with Eli Lilly and Company (Lilly) focused on the discovery, development, and commercialization of novel ...

Many diseases are caused by a missing or defective copy of a single gene. For decades, scientists have been working on gene ...

Stanford Medicine researchers have developed a blood test capable of detecting cancers, the ways cancer resists treatments ...

In 2023, tuberculosis (TB) killed about 1.25 million people worldwide, more than any other infectious disease on Earth — even though it is curable. Months- or even years-long regimens of potent ...